{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:12:52Z","timestamp":1774444372541,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Secretion of parathormone related peptide (PTHrp) is the most common cause of tumor-associated hypercalcemia. This occurs most often in squamous cell carcinomas in the ear nose and throat, bronchial and breast carcinomas. We report a rare case of a PTHrp-producing pancreatic neuroendocrine tumor (pNET) and provide a brief review of the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation:<\/jats:title>\n                    <jats:p>A 68-year-old female patient with epigastric pain and weight loss was diagnosed with a 11 \u00d7 8 \u00d7 9 cm tumor in the pancreatic body with infiltration of the splenic vein and consecutive portal vein thrombosis without evidence of distant metastases. An endosonographic fine needle aspiration revealed a neuroendocrine tumor G2 (Ki-67 3 %). Laboratory analyses showed an asymptomatic hypercalcemia and elevated PTHrp. Distal splenopancreatectomy, left adrenalectomy, thrombectomy of the portal vein, cholecystectomy and partial resection of the left renal vein was performed. Histopathologic examination showed a PTHrp-producing NET of the pancreas G2, pT4 pN0 M0 L0 V2 Pn0 R0. Postoperatively serum levels of PTHrp and calcium dropped to normal values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Up to date only 83 cases of PTHrp producing pNETs have been reported in the English literature. Frequently, as in the reported patient, locally advanced or already distantly metastasized tumors were present. In addition to initial drug control of hypercalcemia, surgical treatment in case of R0 resection offers long-term symptom control and should be performed, when possible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In case of a pancreatic tumor and the simultaneous occurrence of hypercalcemia, the determination of PTHrp should be considered. Surgical resection remains the only curative therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2025.111058","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T12:16:45Z","timestamp":1739362605000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Hypercalcemia due to PTHrp producing pancreas NET: A case report"],"prefix":"10.1097","volume":"128","author":[{"given":"Franziska","family":"Br\u00fcckner","sequence":"first","affiliation":[{"name":"Department of Visceral-, Thoracic- and Vascular Surgery, University Hospital Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Visceral-, Thoracic- and Vascular Surgery, University Hospital Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef K","family":"Bartsch","sequence":"additional","affiliation":[{"name":"Department of Visceral-, Thoracic- and Vascular Surgery, University Hospital Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Rinke","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"5","key":"R1-79-20260325","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner,","year":"2016","journal-title":"J. Oncol. Pract."},{"issue":"10","key":"R2-79-20260325","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/jpm12101553","article-title":"What lies behind paraneoplastic hyperclacemia secondary to well-differentiated neuroendocrine neoplasms? A systematic review of the literature","volume":"12","author":"Giannetta,","year":"2022","journal-title":"J Pers Med."},{"issue":"5","key":"R3-79-20260325","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg Lond Engl"},{"issue":"11","key":"R4-79-20260325","first-page":"3103","article-title":"Parathyroid hormone-like peptide shares features with members of the early response gene family: rapid induction by serum, growth factors and cycloheximide","volume":"52","author":"Allinson,","year":"1992","journal-title":"JCancer Res."},{"issue":"9","key":"R5-79-20260325","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1210\/jc.2014-1315","article-title":"Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management and follow-up","volume":"99","author":"Kamp,","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"R8-79-20260325","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pan.2013.02.007","article-title":"Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors: report of six cases","volume":"13","author":"Milanesi,","year":"2013","journal-title":"Pancreatology"},{"key":"R9-79-20260325","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1197288","article-title":"Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETS): case report","volume":"13","author":"Pitts,","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"R10-79-20260325","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bone.2006.11.009","article-title":"PTHrp, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor","volume":"40","author":"Van den Eynden,","year":"2007","journal-title":"Bone"},{"issue":"12","key":"R11-79-20260325","doi-asserted-by":"crossref","first-page":"548","DOI":"10.46883\/ONC.2020.3412.0548","article-title":"Pancreatic neuroendocrine tumor with humoral hypercalcemia and high tumor PD-L1 score","volume":"34","author":"Copur,","year":"2020","journal-title":"Oncology (Williston Park)"},{"issue":"7","key":"R12-79-20260325","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-2001-17411","article-title":"Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)-associated hypercalcemia of malignancy","volume":"109","author":"Clemens,","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"R13-79-20260325","doi-asserted-by":"crossref","first-page":"153e","DOI":"10.1177\/1636.17936","article-title":"Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumor","volume":"100","author":"Rossi,","year":"2014","journal-title":"Tumori"},{"issue":"3","key":"R14-79-20260325","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ijc.2910460311","article-title":"Parathyroid hormone related protein and hypercalcemia in pancreatic neuroendocrine tumors","volume":"46","author":"Rizzoli,","year":"1990","journal-title":"Int. J. Cancer"},{"issue":"926","key":"R15-79-20260325","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/pmj.78.926.752","article-title":"Presentation of a PTHrP-secreting pancreatic neuroendocirne tumor with hypercalcaemic crisis, pre-eclampsia and renal failure","volume":"78","author":"Abraham,","year":"2002","journal-title":"Postgrad. Med. J."},{"issue":"4","key":"R16-79-20260325","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-240786","article-title":"Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcemia","volume":"14","author":"Ferrel,","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"12","key":"R17-79-20260325","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00595-009-4190-7","article-title":"Pancreatic neuroendocrine cell tumor secreting parathyroid hormone-related protein and gastrin: report of a case","volume":"40","author":"Morita","year":"2010","journal-title":"Surg. Today Dec"},{"key":"R18-79-20260325","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-219692","article-title":"Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET)","volume":"2017","author":"Symington,","year":"2017","journal-title":"BMJ Case Rep."},{"issue":"9","key":"R19-79-20260325","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1097\/RLU.0000000000000862","article-title":"Reversal of severe and refractory humoral hypercalcemia with 177Lu-Octreotate peptide receptor radionuclide therapy for neuroendocrine tumor of the pancreas","volume":"40","author":"Illiuta,","year":"2015","journal-title":"Clin. Nucl. Med."},{"issue":"4","key":"R20-79-20260325","doi-asserted-by":"crossref","first-page":"E627","DOI":"10.1210\/jc.2011-2592","article-title":"Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia","volume":"97","author":"Kanakis,","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"R21-79-20260325","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000151222","article-title":"Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review","volume":"89","author":"Srirajaskanthan,","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"1","key":"R22-79-20260325","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s13256-023-04042-5","article-title":"Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a cease report","volume":"17","author":"Behdadnia,","year":"2023","journal-title":"J Med Case Reports"},{"issue":"3","key":"R23-79-20260325","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MPA.0b013e318267c987","article-title":"Pancreatic neuroendocrine tumor associated with humoral hypercalcemia of malignancy and carcinoid tumor. A case report and review of the literature","volume":"42","author":"Shah,","year":"2013","journal-title":"Pancreas"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225002445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261225002445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2025.111058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:25:35Z","timestamp":1774434335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2025.111058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":21,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2025.111058","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-11-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}